Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides

Experimental Neurology

Volumn 167, Issue 1, 2001, Pages 74-85

  Laskowitz, D T ^a   Thekdi, A D ^a   Thekdi, S D ^a   Han, S K D ^a   Myers, J K ^a   Pizzo, S V ^a   Bennett, E R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E; Microglia; Nitric oxide; Peptides; TNF

Indexed keywords

APOLIPOPROTEIN E; CELL SURFACE RECEPTOR; NITRIC OXIDE; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL ACTIVATION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CIRCULAR DICHROISM; CYTOKINE RELEASE; DOSE RESPONSE; DOWN REGULATION; IMMUNOMODULATION; MICROGLIA; MOUSE; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM;

EID: 0035152093     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7541     Document Type: Article

References (72)

1. ApoE genotype and survival from intracerebral haemorrhage
2. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells
3. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
4. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
5. An immortalized cell line expresses properties of activated microglial cells
6. Motor and cognitive deficits in apolipoprotein-E deficient mice after closed head injury
7. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity
8. NMR Studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles
9. Species differences in the generation of reactive oxygen species by microglia
10. Gene doses of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
11. The biologic activity of the immunoregulatory lipoprotein. LDL-In is independent of its free fatty acid content
12. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection
13. Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response
14. Microglial activation in Alzheimer disease: Association with APOE genotype
15. Lipid binding induced conformational changes in the N-terminal domain of human apolipoprotein E
16. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins
17. Apolipoprotein E-epsilon 4 genotype predicts a poor outcome in survivors of traumatic brain injury
18. Potential role of apolipoprotein-E in fibrillogenesis
19. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis
20. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor
21. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice
22. Inflammatory signals induce neurotropin expression in human microglial cells
23. 39 kDa protein modulates binding of ligands to low density lipoprotein receptor related protein/a2 macroglobulin recptor
24. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line
25. Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia
26. Altered interaction of cis-dichlorodiammineplatinum(II)-modified α2M with the LRP/α2M receptor but not the α2M signaling receptor
27. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation
28. Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology
29. Immunoregulatory plasma lipoproteins: Role of apoprotein E and apoprotein B
30. The receptor-binding domain of human apolipoprotein E: Binding of apolipoprotein E fragments
31. Normalization of receptor binding of apolipoprotein E2: Evidence for modulation of the binding site conformation
32. Establishment of human microglial cell lines after transfection of primary cultures with SV40 large T antigen
33. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid induced toxicity in rat hippocampal pyramidal neuronal cultures
34. Apolipoprotein E epsilon-4 associated with chronic traumatic brain injury in boxing
35. Human apolipoprotein E receptor 2
36. Site-specific mutagenesis of human apolipoprotein E
37. Altered immune responses in apolipoprotein E deficient mice
38. Apolipoprotein E suppresses glial cell secretion of TNFα
39. Apolipoprotein E deficient mice have increased susceptibility to focal cerebral ischemia
40. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric-oxide production
41. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE genotype
42. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
43. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes
44. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
45. The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease
46. Increased 3-nitrotyrosine in brains of Apo E-deficient mice
47. The relationship between low density lipoprotein-related protein/α2M receptors and the newly described alpha 2 macroglobulin signaling receptor
48. APOE3 and APOE4 binding to macrophages triggers inositol (1,4,5-) trisphosphate mediated increases in intracellular calcium
49. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
50. Angiostatin binds ATP synthase on the surface of human endothelial cells
51. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide
52. Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-agatoxin IVa-sensitire Ca2+-channel
53. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
54. A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse
55. Reactive microglia in aging and dementia: An immunohistochemical study of postmortem human brain tissue
56. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In
57. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
58. Evolution of apolipoprotein E: Mouse sequence and evidence for an 11-nucleotide ancestral unit
59. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo
60. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
61. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice
62. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse
63. Apolipoprotein E epsilon4 and the risk of dementia with stroke: A population-based investigation
64. ApoE as a prognostic factor for post-traumatic coma
65. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
66. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease
67. Preliminary report of a genetic basis for cognitive decline after cardiac operations: The Neurologic Outcome Research Group of the Duke Heart Center
68. Association of apolipoprotein E polymorphism with outcome after head injury
69. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated
70. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity
71. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
72. Apolipoprotein E: Structure-function relationships